Hydrochlorothiazide
INZIRQO
Thiazide Diuretic
NADAC/unit
$0.0121
Active Shortage
Tier 1: 389.7%
PA Req: 0.6%
11 Manufacturers
27 ANDAs
Hydrochlorothiazide reduces fluid retention and lowers blood pressure by increasing urine output.
vs. brand INZIRQO: Generic saves up to 100% per unit
Active Shortages
2025-11-19 A business decision was made to discontinue manufacture of the drug., Teva Pharmaceuticals USA, Inc.
2025-11-19 A business decision was made to discontinue manufacture of the drug., Teva Pharmaceuticals USA, Inc.
2023-01-19 Discontinuation of the manufacture of the drug, Aurobindo Pharma USA
2023-01-19 Discontinuation of the manufacture of the drug, Aurobindo Pharma USA
2023-01-19 Discontinuation of the manufacture of the drug, Aurobindo Pharma USA
Generic Manufacturers
ACCORD HEALTHCARE INCACTAVIS ELIZABETH LLCAUROBINDO PHARMA LTDHERITAGE PHARMACEUTICALS INC DBA AVET PHARMACEUTICALS INCIVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USAJUBILANT CADISTA PHARMACEUTICALS INCLEADING PHARMA LLCNOVITIUM PHARMA LLCOXFORD PHARMACEUTICALS LLCPRINSTON PHARMACEUTICAL INCSCIEGEN PHARMACEUTICALS INCTEVA BRANDED PHARMACEUTICAL PRODUCTS R AND D LLCUNICHEM LABORATORIES LTD
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.